Phage therapy program
Westmead Hospital / Westmead Institute for Medical Research phage team
| Status | Official referral/inquiry route |
|---|---|
| Type | Center |
| Location | Westmead; Australia |
| Entry review | 2026-10-03 |
Access and enquiries
| How to enquire | Established clinical/compassionate-use program within Phage Australia; use its Australian-registered infectious-diseases specialist referral pathway. WIMR’s general research contact is not an independent patient intake form. |
|---|---|
| Areas of work | Personalized phage therapy for difficult-to-treat bacterial infections, including clinical trials and compassionate-use cases. In October 2022, STAMP administered its first patient dose of locally produced phages at Westmead. |
| International access | Same network requirement: Australian-registered infectious-diseases specialist; no separate international eligibility statement verified. |
What to confirm
- Network and hospital are distinct entity records but one connected access pathway, not two independent services.
Related studies(1)
STAMP
Recruiting
Recorded program–study link. Website
Sources and updates
Entry reviewed . This is the date of our source review, not a confirmation of availability today.
- WIMR Phage Therapy Group
- Phage Australia patient information
- Phage Australia STAMP milestones
- ANZCTR ACTRN12621001526864 — STAMP
- ABC News — Phage therapy offers hope in fight against antibiotic resistance and superbugs
AI helped us research this directory. Details may be wrong or out of date. Confirm availability with the clinic or study team. Suggest a correction.
| Program ID | au-westmead |
|---|